Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$16.95 - $27.04 $1.03 Million - $1.64 Million
-60,691 Reduced 56.96%
45,857 $1.24 Million
Q1 2024

May 14, 2024

BUY
$11.38 - $19.03 $38,612 - $64,568
3,393 Added 3.29%
106,548 $1.95 Million
Q4 2023

Feb 13, 2024

BUY
$6.29 - $15.72 $321,601 - $803,747
51,129 Added 98.28%
103,155 $1.27 Million
Q3 2023

Nov 13, 2023

SELL
$14.99 - $32.65 $490,607 - $1.07 Million
-32,729 Reduced 38.62%
52,026 $779,000
Q2 2023

Aug 14, 2023

SELL
$29.76 - $46.14 $2.21 Million - $3.43 Million
-74,377 Reduced 46.74%
84,755 $2.75 Million
Q1 2023

May 15, 2023

BUY
$38.09 - $57.79 $3.99 Million - $6.05 Million
104,765 Added 192.7%
159,132 $6.23 Million
Q4 2022

Feb 14, 2023

BUY
$40.54 - $56.2 $2.2 Million - $3.06 Million
54,367 New
54,367 $2.87 Million
Q3 2021

Nov 12, 2021

SELL
$44.0 - $65.8 $217,404 - $325,117
-4,941 Closed
0 $0
Q2 2021

Aug 13, 2021

SELL
$44.66 - $63.06 $223,612 - $315,741
-5,007 Reduced 50.33%
4,941 $236,000
Q1 2021

May 14, 2021

BUY
$46.31 - $62.7 $460,691 - $623,739
9,948 New
9,948 $504,000

Others Institutions Holding SILK

About Silk Road Medical Inc


  • Ticker SILK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,565,600
  • Market Cap $1.03B
  • Description
  • Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate te...
More about SILK
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.